Our client, Illumina, was recently named by the MIT Technology Review as one of the 50 smartest companies of 2016. Finishing just ahead of companies like Tesla Motors, Facebook, and Microsoft. To see the rest of the companies on the list, check out the MIT site.
The world’s largest DNA-sequencing company hopes to expand its technology’s role in diagnosing illness. This year it formed a new company to develop blood tests that cost $1,000 or less and can detect many types of cancer before symptoms arise, greatly improving the chances of survival. The spinoff, called Grail, is being headed by Jeff Huber, a former senior Google executive who lost his wife to colon cancer. The testing concept, sometimes called a “liquid biopsy,” uses Illumina’s high-speed sequencing machines to scour a person’s blood for fragments of DNA released by cancer cells.
At LESS+MORE, we are thrilled to continue our partnership with the growing company. We recently partnered with them and created a printed piece for employees and candidates to showcase the unique culture at Illumina. In addition to design, we commissioned photo shoots in three cities to convey an authentic portrait of daily life at the company. Check out some project highlights from our recent work with Illumina.